Patient Centered Diabetes Care 2015

This session was sponsored by Regeneron.

Statins have been the mainstay of LDL cholesterol management for 20 years, but can the PCSK9 inhibitors do more for some patients?

Integrating behavioral health care into the space where care for diabetes occurs can be aided by new delivery models and by technology, panelists say.

Glooko, a mobile support platform for diabetes care, helps fill the gaps created by the shortage of endocrinologists. Self-care is key to reducing the number of hypoglycemia incidents.

Combination therapy in diabetes care can offer benefits but might not be right for certain populations or at certain stages of care.

Trials that lead to FDA approval provide payers little information about the comparative differences between new therapies, and especially for their value for individual patients.

Lifestyle change can produce dramatic results in health outcomes, but motivating patients can prove very difficult, panelists at the session during Patient Centered Diabetes Care agreed.

Considerations such as the potency of the drug, the practicality of the regimen, and the price go into decision-making.

In the keynote presentation at Patient-Centered Diabetes Care 2015, Robert A. Gabbay, MD, PhD, discusses how new payment models can improve care in both type 1 and type 2 diabetes.

What patients have heard from others with diabetes matters when they receive a diagnosis, according to the opening speaker at Patient-Centered Diabetes Care 2015.

Social media can give persons with #diabetes information they can't get elsewhere, but doctors aren't always ready to send patients websites because they may fear the information is unreliable.

The Dietary Guidelines Advisory Committee broke new ground in 2015 by looking at overall dietary patterns in announcing its findings, according to member Frank Hu, MD, MPH, PhD, of the Harvard School of Public Health.